PACTR202308591985746

Magnesium sulphate versus dexmedetomidine for cough suppression during anesthetic emergence in smokers: A randomized double _ blind controlled trial

faculty of medicine ain shams university·Phase 4·Pan Africa Clinical Trials RegistryRecruiting
Study focus
Disease/Condition
Anaesthesia
Sponsor & location
Primary sponsor
faculty of medicine ain shams university
Funder
no
Location
Egypt
Timeline & enrollment
Phase
Phase 4
Start date
Jul 20, 2022
End date
Sep 07, 2023
Summary

Cough during the perioperative period is usually transient and self-limiting. On emergence from anesthesia, cough may protect against aspiration. However, cough can also result in perioperative morbidity, including tachyarrhythmia, arterial hypertension, cardiovascular collapse, and airway complications, and it may increase intracranial, intra abdominal, and intraocular pressure .Cigarette smokers known to have respiratory problems during induction of anesthesia with increased incidence of laryngospasm and cough during extubation as the integrity of epithelium lost by smoke irritation.Multiple medications have been shown to reduce emergence coughing, such as lidocaine (i.v., intracuff, topical, and tracheal routes), dexmedetomidine, fentanyl, and remifentanil.The aim of this study is to investigate and compare the effect of dexmedetomidine and magnesium sulphate on the prevention of emergence cough after general anesthesia in smokers performing lower abdominal surgeries.

ICD-10 classifications
Anaesthetic, unspecifiedOther and unspecified general anaestheticsOther complications of anaesthesiaLocal anaestheticsAnaesthesia of skin
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202308591985746
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202308591985746 through Pure Global AI's free database. This Phase 4 trial is sponsored by faculty of medicine ain shams university and is currently Recruiting. The study focuses on Anaesthesia.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.